Association between Blood Pressure and HIV Status in Rural Uganda: Results of Cross-Sectional Analysis.


Journal

Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391

Informations de publication

Date de publication:
10 02 2021
Historique:
entrez: 18 2 2021
pubmed: 19 2 2021
medline: 26 10 2021
Statut: epublish

Résumé

The association between HIV status and hypertension is not well described within sub-Saharan Africa. We examined prevalence and risk factors for hypertension among HIV positive and negative individuals living in a rural district of Uganda. We conducted a cross-sectional analysis in two concurrent cohorts of 600 HIV negative and 721 HIV seropositive individuals aged ≥35 years. Of the 721 HIV positive participants, 59.8% were women and the median age was 44.3 years, while for HIV negative individuals, 55% were women and the median age was 47.8 years. Over 90% of HIV positive individuals were on antiretroviral treatment. The prevalence of hypertension (≥140/≥90 mmHg) was 33.5% in HIV negative individuals and 23.9% in HIV positive individuals. Age (adjusted OR = 1.05, 95% CI 1.03 to 1.06) and BMI (adjusted OR = 1.08, 95% CI 1.05 to 1.12) were associated with higher odds of hypertension. Having HIV was associated with lower odds of hypertension (adjusted OR = 0.66, 95% CI 0.50 to 0.88), lower systolic blood pressure (-5.1 mmHg, 95% CI: -7.4 to -2.4) and lower diastolic blood pressure (-4.0 mmHg, 95% CI: -5.6 to -2.5). We did not observe differences in the odds of hypertension by CD4 count, viral load or ART among HIV positive individuals in this sample. Hypertension was prevalent in one third of HIV negative individuals and in one fourth of HIV positive patients. While access to health information among individuals attending HIV clinics may explain observed differences, more research is needed to understand plausible biological and social mechanisms that could explain lower blood pressure among people living with HIV in Uganda.

Identifiants

pubmed: 33598392
doi: 10.5334/gh.858
pmc: PMC7880004
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009340
Pays : United States

Informations de copyright

Copyright: © 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

PLoS One. 2015 Sep 25;10(9):e0138991
pubmed: 26406462
Int J Hypertens. 2018 Apr 26;2018:8307591
pubmed: 29854433
Epidemiology. 2003 Nov;14(6):680-6
pubmed: 14569183
Lancet Infect Dis. 2010 Apr;10(4):251-61
pubmed: 20334848
J Hum Hypertens. 2016 Jun;30(6):355-62
pubmed: 26446389
Curr Opin Pharmacol. 2015 Apr;21:14-9
pubmed: 25523165
J Int AIDS Soc. 2019 Mar;22(3):e25213
pubmed: 30916897
PLoS One. 2018 Dec 31;13(12):e0208635
pubmed: 30596667
BMJ Glob Health. 2016 Nov 24;1(3):e000055
pubmed: 28588953
Hypertension. 2018 Jul;72(1):44-55
pubmed: 29776989
PLoS One. 2016 May 27;11(5):e0156309
pubmed: 27232186
Open Forum Infect Dis. 2016 Oct 8;3(4):ofw213
pubmed: 27942541
Bull World Health Organ. 2015 Jul 1;93(7):457-67
pubmed: 26170503
Blood Press. 2012 Oct;21(5):311-9
pubmed: 22564000
J Am Soc Hypertens. 2017 Aug;11(8):530-540
pubmed: 28689734
J Cardiovasc Med (Hagerstown). 2013 Aug;14(8):553-8
pubmed: 23807242
J Hum Hypertens. 2020 Oct;34(10):692-708
pubmed: 32709885
COPD. 2020 Jun;17(3):297-305
pubmed: 32462945
BMC Public Health. 2015 Aug 28;15:830
pubmed: 26315787
Vasc Health Risk Manag. 2014 Mar 18;10:129-37
pubmed: 24672244
Int J Hypertens. 2018 Jan 22;2018:1691474
pubmed: 29610680
Bull World Health Organ. 2019 May 1;97(5):318-327
pubmed: 31551628

Auteurs

Anxious J Niwaha (AJ)

Non-Communicable Diseases (NCD) Theme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, UG.

Adaeze C Wosu (AC)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, US.
Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland, US.

Alex Kayongo (A)

School of Medicine, Makerere University College of Health Sciences, Kampala, UG.
Lung Institute, Makerere University College of Health Sciences, Kampala, UG.

Charles Batte (C)

School of Medicine, Makerere University College of Health Sciences, Kampala, UG.
Lung Institute, Makerere University College of Health Sciences, Kampala, UG.

Trishul Siddharthan (T)

Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland, US.
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, US.

Robert Kalyesubula (R)

School of Medicine, Makerere University College of Health Sciences, Kampala, UG.
African Community Center for Social Sustainability (ACCESS), Nakaseke, UG.

Bruce Kirenga (B)

School of Medicine, Makerere University College of Health Sciences, Kampala, UG.
Lung Institute, Makerere University College of Health Sciences, Kampala, UG.

William Checkley (W)

Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland, US.
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, US.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH